Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1994 Feb 25;22(4):569–575. doi: 10.1093/nar/22.4.569

Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter.

J S Lee 1, L Catanzariti 1, B A Hemmings 1, B Kiefer 1, Y Nagamine 1
PMCID: PMC307845  PMID: 8127705

Abstract

In LLC-PK1 cells, the urokinase-type plasminogen activator (uPA) gene is induced by two of the major signal transduction pathways, the protein kinase C (PKC) and the cAMP-dependent protein kinase (PKA) pathways. We have analyzed the chromatin structure of 26 kb of the uPA gene locus and have shown that PKA activation but not PKC activation induce major chromatin structural alterations in the uPA gene promoter. In uninduced cells, several DNase I hypersensitive (HS) sites were detected in the 5' and 3' flanking regions but not in the transcribed region. Two of the sites correspond to previously characterized regulatory sites: a cAMP responsive site at nucleotide position -3500 with respect to the initiation site, and the PEA3/AP1 site at -2100 that mediates PKC activation. After the activation of PKA but not PKC, a strong HS site was induced at -2600. Functional analysis of this region revealed cAMP responsive activity. Chromatin structural alterations again brought about specifically by PKA but not by PKC were were also detected in the upstream of the promoter by topoisomerase I cleavage site analysis, with two prominent sites appearing at -2800 and -3300. These results suggest that the strong cAMP induction of the uPA gene requires structural alterations that permit cooperative interactions between the multiple cAMP responsive sites.

Full text

PDF
569

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrus L., Altus M. S., Pearson D., Grattan M., Nagamine Y. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP. J Biol Chem. 1988 May 5;263(13):6183–6187. [PubMed] [Google Scholar]
  2. Benvenisty N., Reshef L. Developmental acquisition of DNase I sensitivity of the phosphoenolpyruvate carboxykinase (GTP) gene in rat liver. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1132–1136. doi: 10.1073/pnas.84.5.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borrelli E., Montmayeur J. P., Foulkes N. S., Sassone-Corsi P. Signal transduction and gene control: the cAMP pathway. Crit Rev Oncog. 1992;3(4):321–338. [PubMed] [Google Scholar]
  4. Botteri F. M., Ballmer-Hofer K., Rajput B., Nagamine Y. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression. J Biol Chem. 1990 Aug 5;265(22):13327–13334. [PubMed] [Google Scholar]
  5. Cassady A. I., Stacey K. J., Nimmo K. A., Murphy K. M., von der Ahe D., Pearson D., Botteri F. M., Nagamine Y., Hume D. A. Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig. Nucleic Acids Res. 1991 Dec 25;19(24):6839–6847. doi: 10.1093/nar/19.24.6839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
  7. Degen J. L., Estensen R. D., Nagamine Y., Reich E. Induction and desensitization of plasminogen activator gene expression by tumor promoters. J Biol Chem. 1985 Oct 15;260(23):12426–12433. [PubMed] [Google Scholar]
  8. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  9. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gross D. S., Garrard W. T. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem. 1988;57:159–197. doi: 10.1146/annurev.bi.57.070188.001111. [DOI] [PubMed] [Google Scholar]
  11. Hull R. N., Cherry W. R., Weaver G. W. The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro. 1976 Oct;12(10):670–677. doi: 10.1007/BF02797469. [DOI] [PubMed] [Google Scholar]
  12. Kaye J. S., Pratt-Kaye S., Bellard M., Dretzen G., Bellard F., Chambon P. Steroid hormone dependence of four DNase I-hypersensitive regions located within the 7000-bp 5'-flanking segment of the ovalbumin gene. EMBO J. 1986 Feb;5(2):277–285. doi: 10.1002/j.1460-2075.1986.tb04210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee J. S., von der Ahe D., Kiefer B., Nagamine Y. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells. Nucleic Acids Res. 1993 Jul 25;21(15):3365–3372. doi: 10.1093/nar/21.15.3365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Menoud P. A., Matthies R., Hofsteenge J., Nagamine Y. Purification and cDNA cloning of a transcription factor which functionally cooperates within a cAMP regulatory unit in the porcine uPA gene. Nucleic Acids Res. 1993 Apr 25;21(8):1845–1852. doi: 10.1093/nar/21.8.1845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milman G., Herzberg M. Efficient DNA transfection and rapid assay for thymidine kinase activity and viral antigenic determinants. Somatic Cell Genet. 1981 Mar;7(2):161–170. doi: 10.1007/BF01567655. [DOI] [PubMed] [Google Scholar]
  16. Nagamine Y., Sudol M., Reich E. Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell. 1983 Apr;32(4):1181–1190. doi: 10.1016/0092-8674(83)90301-x. [DOI] [PubMed] [Google Scholar]
  17. Nagamine Y., Ziegler A. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition. EMBO J. 1991 Jan;10(1):117–122. doi: 10.1002/j.1460-2075.1991.tb07927.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakagawa J., von der Ahe D., Pearson D., Hemmings B. A., Shibahara S., Nagamine Y. Transcriptional regulation of a plasminogen activator gene by cyclic AMP in a homologous cell-free system. Involvement of cyclic AMP-dependent protein kinase in transcriptional control. J Biol Chem. 1988 Feb 15;263(5):2460–2468. [PubMed] [Google Scholar]
  19. Stewart A. F., Herrera R. E., Nordheim A. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities. Cell. 1990 Jan 12;60(1):141–149. doi: 10.1016/0092-8674(90)90724-s. [DOI] [PubMed] [Google Scholar]
  20. Stewart A. F., Reik A., Schütz G. A simpler and better method to cleave chromatin with DNase 1 for hypersensitive site analyses. Nucleic Acids Res. 1991 Jun 11;19(11):3157–3157. doi: 10.1093/nar/19.11.3157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stewart A. F., Schütz G. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Cell. 1987 Sep 25;50(7):1109–1117. doi: 10.1016/0092-8674(87)90177-2. [DOI] [PubMed] [Google Scholar]
  22. Vosberg H. P. DNA topoisomerases: enzymes that control DNA conformation. Curr Top Microbiol Immunol. 1985;114:19–102. doi: 10.1007/978-3-642-70227-3_2. [DOI] [PubMed] [Google Scholar]
  23. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1985;54:665–697. doi: 10.1146/annurev.bi.54.070185.003313. [DOI] [PubMed] [Google Scholar]
  24. Weintraub H. Assembly of an active chromatin structure during replication. Nucleic Acids Res. 1979 Oct 10;7(3):781–792. doi: 10.1093/nar/7.3.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Weintraub H., Beug H., Groudine M., Graf T. Temperature-sensitive changes in the structure of globin chromatin in lines of red cell precursors transformed by ts-AEV. Cell. 1982 Apr;28(4):931–940. doi: 10.1016/0092-8674(82)90072-1. [DOI] [PubMed] [Google Scholar]
  26. Workman J. L., Buchman A. R. Multiple functions of nucleosomes and regulatory factors in transcription. Trends Biochem Sci. 1993 Mar;18(3):90–95. doi: 10.1016/0968-0004(93)90160-o. [DOI] [PubMed] [Google Scholar]
  27. Zaret K. S., Yamamoto K. R. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell. 1984 Aug;38(1):29–38. doi: 10.1016/0092-8674(84)90523-3. [DOI] [PubMed] [Google Scholar]
  28. Ziegler A., Hagmann J., Kiefer B., Nagamine Y. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism. J Biol Chem. 1990 Dec 5;265(34):21194–21201. [PubMed] [Google Scholar]
  29. van Holde K. Transcription. The omnipotent nucleosome. Nature. 1993 Mar 11;362(6416):111–112. doi: 10.1038/362111a0. [DOI] [PubMed] [Google Scholar]
  30. von der Ahe D., Pearson D., Nagamine Y. Macromolecular interaction on a cAMP responsive region in the urokinase-type plasminogen activator gene: a role of protein phosphorylation. Nucleic Acids Res. 1990 Apr 25;18(8):1991–1999. doi: 10.1093/nar/18.8.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES